-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5

Benzinga·12/03/2025 17:58:08
Listen to the news
Roth Capital analyst Kyle Bauser initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $5.5.